Congressional Trader
Live

DXCM congressional trades

9 matched disclosures

Track congressional trades for DXCM
Tracked disclosures
9
Lawmakers
5
Buy / sell
4 / 5
Avg post-trade move
-8.0%
Latest filing 2026-05-10

DXCM congressional trades snapshot

This page summarizes public STOCK Act disclosures involving DXCM. It is useful for seeing which lawmakers reported DXCM transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

May 10, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the DXCM congressional trade page shows

Congressional Trader tracks 9 public STOCK Act disclosures for DXCMacross 5 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent DXCM filing shown here was filed on May 10, 2026 by Tina Smith as a partial sale. Related lawmakers include Jefferson Shreve, Robert P. Bresnahan, John Boozman, Kevin Hern, Tina Smith.

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
Tina SmithD-MNSenate
No committee data
Filed May 10, 2026
Delay 11 days
View filing
DexCom, Inc. - Common Stock
Partial sale
$100K - $250K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
John BoozmanR-ARSenate
No committee data
Filed Feb 15, 2026
Delay 20 days
View filing
Dexcom Inc
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Jun 22, 2025
Delay 41 days
View filing
DexCom, Inc. - Common Stock
Sale
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Jun 22, 2025
Delay 45 days
View filing
DXCMNotable
DexCom, Inc. - Common Stock
Purchase
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Jun 9, 2025
Delay 25 days
View filing
DXCMNotable
DexCom, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 8, 2025
Delay 31 days
View filing
DXCMNotable
DexCom, Inc. - Common Stock
Sale
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Apr 28, 2025
Delay 20 days
View filing
DXCMNotable
DexCom, Inc. - Common Stock
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Mar 27, 2025
Delay 30 days
View filing
DexCom, Inc. - Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Kevin HernR-OKHouse
No committee data
Filed Jan 15, 2025
Delay 15 days
View filing
DexCom, Inc. - Common Stock
Sale
$50K - $100K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded DXCM?

Recent DXCM disclosures include Jefferson Shreve, Robert P. Bresnahan, John Boozman, Kevin Hern, Tina Smith.

What is the buy/sell mix for DXCM?

The visible sample currently shows 4 purchases and 5 sales or partial sales.

Should I trade based on DXCM disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.

DXCM Congressional Trades | Congressional Trader